Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes
Study Details
Study Description
Brief Summary
This study was made to compare the efficacy of topical ibuprofen in gel form with oral ibuprofen in the treatment of sub-acute soft tissue injuries while comparing the tolerability of the delivery methods
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: 1 Active ibuprofen liposomal transdermal gel with placebo ibuprofen capsule |
Drug: ibuprofen
Apply by rubbing into skin for 30 to 60 seconds active ibuprofen 10% gel, 0.5cc to skin over injured area 3 times a day and taking placebo capsules of ibuprofen 3 times a day 10-40mg/kg per day, not to exceed 1200mg per day for 2 weeks.
|
Other: 2 Placebo ibuprofen liposomal transdermal gel with active ibuprofen capsules |
Drug: Ibuprofen
Apply by rubbing into skin for 30 to 60 seconds placebo ibuprofen 10% gel, 0.5cc to skin over injured area 3 times a day and taking active capsules of ibuprofen 3 times a day 10-40mg/kg per day, not to exceed 1200mg per day for 2 weeks.
|
Outcome Measures
Primary Outcome Measures
- Efficacy of Topical Ibuprofen to Oral Ibuprofen measured by numeric pain rating, swelling at injury site, and change in sports activity. [10 days to 8 weeks after initial injury or flare up]
Secondary Outcome Measures
- Compare the tolerability of the two delivery methods measured by side effects. [2 weeks after starting topical and oral ibuprofen]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 12-19yo
-
soft tissue injury or flare up of soft tissue injury within 10 days to 8 weeks
Exclusion Criteria:
-
Known hypersensitivity to aspirin or any NSAID,
-
allergy to eggs or egg products
-
history of asthma, renal disease, GI disease, active or suspected bleeding peptic ulcer (past or present), anemia, hypertension, other systemic disease significantly affecting liver or renal function
-
serious injury within six months
-
currently on anticoagulants
-
pregnant or lactating females
-
active arthritis in affected limb
-
open wounds, infected skin or fractures
-
opioid use within 7 days
-
severe psychological disorder
-
prior topical medication applied to the painful region/area of study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Sports Medicine Department at Akron Children's Hospital | Akron | Ohio | United States | 44308 |
Sponsors and Collaborators
- Akron Children's Hospital
Investigators
- Principal Investigator: Emmanuel O Adekunle, M.D., Akron Children's Hospital
- Study Director: Joseph Congeni, M.D., Akron Children's Hospital
- Principal Investigator: Cynthia Bennett, MSN, CNP, Akron Children's Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
- IRB #0600210